Skip to content

Outcomes of meningomyelocele repair with or without platelet rich plasma application

Outcomes of meningomyelocele repair with or without platelet rich plasma application in patients with meningomyelocele

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000199415
Enrollment
70
Registered
2025-02-20
Start date
2024-07-15
Completion date
2024-11-01
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

During meningomyelocele repair, a neural plate was formed and watertight dural closure is done. After achieving hemostasis, platelet rich plasma was applied over dural repair and wound edges. Study purpose is to compare outcome of meningomyelocele repair with or without platelet rich plasma in terms of preventing CSF leakage, meningitis and wound dehiscence. Hypothesis: Platelet rich plasma during meningomyelocele repair prevent cerebrospinal fluid leakage, promotes healing and reduce mortality.

Interventions

To compare outcome of meningomyelocele repair with or without platelet rich plasma in terms of preventing cerebrospinal fluid leakage, meningitis and wound infection. During meningomyelocele repair, a neural plate was formed and watertight dural closure was done. After achieving hemostasis, Platelet rich plasma was applied over dural repair and wound edges. b) Platelet rich plasma will be obtained by centrifugation at 200 g at 22 degree celcius for 10 minutes. Then uppermost layer will again b

To compare outcome of meningomyelocele repair with or without platelet rich plasma in terms of preventing cerebrospinal fluid leakage, meningitis and wound infection. During meningomyelocele repair, a neural plate was formed and watertight dural closure was done. After achieving hemostasis, Platelet rich plasma was applied over dural repair and wound edges. b) Platelet rich plasma will be obtained by centrifugation at 200 g at 22 degree celcius for 10 minutes. Then uppermost layer will again be transferred into another centrifugation tube by using sterile pipette and this will again centrifugate at 400g at 22 degree celcius . Around 1ml of Platelet rich plasma will be obtained by this two step method. All this will be done pre operatively to save time. c) Surgeon will do the intervention. d) Intervention requires fifteen to thirty minutes. e) Direct observation of the surgery is required to assess adherence to surgery

Sponsors

Dr Mahwish Noor ul haq
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
2 Days to 1 Years
Healthy volunteers
No

Inclusion criteria

Patients with meningomyelocele of both genders and age between 2 days to 1 years.

Exclusion criteria

Patients presenting with meningitis. Patients presenting with sepsis.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026